Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On January 9, 2021, Dynavax Technologies Corporation (the "Company") adopted the Dynavax Technologies Corporation 2021 Inducement Award Plan (the "Inducement Plan"), pursuant to which the Company reserved 1,500,000 shares of its common stock for issuance under the Inducement Plan to be used exclusively for grants of awards to individuals who were not previously employees or directors of the Company, as an inducement material to the individual's entry into employment with the Company within the meaning of Nasdaq Listing Rule 5635(c)(4). The Inducement Plan was approved by the Compensation Committee of the Board of Directors of the Company without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4).

The foregoing description of the terms of the Inducement Plan is not intended to be complete and is qualified in its entirety by reference to the Inducement Plan and the forms of award agreements adopted under the Inducement Plan, copies of which are included hereto as Exhibit 10.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits. The following exhibit is furnished herewith:



  Number          Description
10.1       Dynavax Technologies Corporation 2021 Inducement Award Plan, Form of
         Stock Option Grant Notice, Option Agreement, Form of Restricted Stock
         Grant Notice and Restricted Stock Unit Award Agreement  .
104      Cover Page Interactive Data File (embedded within the Inline XBRL
         document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses